drugset / Trial / NCT03338387

Co-Feedback Action of Growth Hormone, PP and PYY on Ghrelin in Bulimia

NCT03338387

Phase 2 Enrolling by invitation 24 enrolled Charles University, Czech Republic
RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates the addition of Acipimox or placebo to exercise on growth hormone release and ghrelin secretion in bulimic patients and in healthy women. Two groups of participants will receive Acipimox together with exercise versus identical placebo with exercise.

Timeline

Start
2003-05-06
Primary completion
2007-12-16
Completion
2026-12-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acipimox Small molecule

Indications